Stock Earnings

Question 1

Báo cáo tài chính chính của Takeda Pharmaceutical Co Ltd là gì?

Accepted Answer

Theo báo cáo tài chính mới nhất (Form-10K), Takeda Pharmaceutical Co Ltd có tổng tài sản là $14,248,344, lợi nhuận ròng profit là $107,928

Question 2

Tỷ lệ tài chính chính của TKPHF là gì?

Accepted Answer

Tỷ lệ thanh khoản của Takeda Pharmaceutical Co Ltd là 1.94, tỷ suất lợi nhuận ròng là 2.35, doanh thu trên mỗi cổ phiếu là $2,901.78.

Question 3

Doanh thu của Takeda Pharmaceutical Co Ltd được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?

Accepted Answer

Takeda Pharmaceutical Co Ltd largest revenue segment is Gastroenterology Revenue (Pre-FY2023 Reporting), at a revenue of 1,216,207,000,000 in the most earnings release.For geography, Japan is the primary market for Takeda Pharmaceutical Co Ltd, at a revenue of 418,462,000,000.

Question 4

Takeda Pharmaceutical Co Ltd có lợi nhuận không?

Accepted Answer

yes, theo báo cáo tài chính mới nhất, Takeda Pharmaceutical Co Ltd có lợi nhuận ròng profit là $107,928

Question 5

Takeda Pharmaceutical Co Ltd có nợ không?

Accepted Answer

yes, Takeda Pharmaceutical Co Ltd có nợ là 7,313,260

Question 6

Takeda Pharmaceutical Co Ltd có bao nhiêu cổ phiếu đang lưu hành?

Accepted Answer

Takeda Pharmaceutical Co Ltd có tổng cộng 1,573.64 cổ phiếu đang lưu hành

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	4,417,004	4,581,551	4,263,762	4,027,478	3,569,006	3,197,812
Revenue Growth (YoY)	-3%	7%	6%	13%	12%	-3%
Cost of Revenue	1,563,688	1,580,217	1,426,678	1,244,072	1,106,846	994,308
Gross Profit	2,853,316	3,001,334	2,837,084	2,783,406	2,462,160	2,203,504
Selling, General & Admin	1,075,890	1,104,766	1,053,819	997,309	886,361	875,663
Research & Development	691,573	730,227	729,924	633,325	526,087	455,833
Operating Expenses	2,479,739	2,464,303	2,406,297	2,232,511	1,916,672	1,867,782
Other Non Operating Income (Expenses)	1	0	1	--	1	--
Pretax Income	97,912	175,084	52,791	375,090	302,571	366,235
Income Tax Expense	64,625	66,941	-91,406	58,052	72,405	-9,936
Net Income	33,075	107,928	144,067	317,017	230,059	376,005
Net Income Growth	-89%	-25%	-55%	38%	-39%	750%
Shares Outstanding (Diluted)	1,577.46	1,578.87	1,564.45	1,569.87	1,577.16	1,573.53
Shares Change (YoY)	-2%	1%	0%	0%	0%	0%
EPS (Diluted)	20.96	68.35	92.08	201.93	145.86	238.95
EPS Growth	-88%	-26%	-54%	38%	-39%	746%
Free Cash Flow	922,298	709,341	235,614	343,467	937,068	774,463
Free Cash Flow Per Share	584.67	449.27	150.6	218.78	594.14	492.17
Gross Margin	64.59%	65.5%	66.53%	69.11%	68.98%	68.9%
Operating Margin	8.45%	11.72%	10.1%	13.67%	15.28%	10.49%
Profit Margin	0.74%	2.35%	3.37%	7.87%	6.44%	11.75%
Free Cash Flow Margin	20.88%	15.48%	5.52%	8.52%	26.25%	24.21%
EBITDA	1,116,919	1,298,427	1,158,789	1,215,295	1,128,639	895,393
EBITDA Margin	25.28%	28.34%	27.17%	30.17%	31.62%	28%
D&A For EBITDA	743,342	761,396	728,002	664,400	583,151	559,671
EBIT	373,577	537,031	430,787	550,895	545,488	335,722
EBIT Margin	8.45%	11.72%	10.1%	13.67%	15.28%	10.49%
Effective Tax Rate	66%	38.23%	-173.14%	15.47%	23.92%	-2.71%

Takeda Pharmaceutical Co Ltd (TKPHF) Price

TKPHF Stock Price Chart

TKPHF Income

Follow-Up Questions